Dopamine Agents - Pharmacology
Research News and Information

Saturday, November 21, 2009

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.

7 Sep 2009 CONTEXT: Kidney graft function after transplantation can be improved through pharmacological donor pretreatment to limit organ injury from cold preservation. OBJECTIVE: To determine whether pretreatment of brain-dead donors with low-dose dopamine ... Read more...

Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.

20 Aug 2009 Amphetamine (AMPH) increases brain dopamine (DA) levels via reversal of the membrane DA transporter. Additional mechanisms have been suggested, including inhibition of vesicular monoamine transporters and vesicular leakage of DA and Ca(2+). ... Read more...

Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.

26 Jul 2009 GPR88, an orphan G protein-coupled receptor, was designated Strg/GPR88 for striatum-specific G protein-coupled receptor (K. Mizushima et al. (2000)Genomics, 69, 314-321). In this study, we focused on striatal GPR88 protein localization using a ... Read more...

Latest indexed articles for 'Dopamine Agents - Pharmacology'

These are the very latest articles for this heading:

• Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. 7 Sep 2009
• Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure. 20 Aug 2009
• Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. 26 Jul 2009
• Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa. 21 Jul 2009
• Identification and characterization of a novel amphioxus dopamine D-like receptor. 21 Jul 2009
• Differential dopaminergic modulation of neostriatal synaptic connections of striatopallidal axon collaterals. 13 Jul 2009
• Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. 7 Jul 2009
• An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. 29 Jun 2009
• Arrestin3 mediates D(2) dopamine receptor internalization. 29 Jun 2009
• Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. 29 Jun 2009
• Dopamine signaling is required for depolarization-induced slow current in cerebellar Purkinje cells. 29 Jun 2009
• Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. 28 Jun 2009
• Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. 22 Jun 2009
• Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine-deficient phenotype. 15 Jun 2009
• Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. 8 Jun 2009
• L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. Jun 2009
• Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa). 30 May 2009
• Analysis of interactive effect of stretch reflex and shortening reaction on rigidity in Parkinson's disease. 29 May 2009
• Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. 25 May 2009
• Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. 21 May 2009

See a longer list of these articles.

Technical information about 'Dopamine Agents'

Definition: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Registry Number: 0

Descriptor UI: D015259

Alternative terms: Dopamine Agents; Agents, Dopamine; Dopaminergic Drugs; Drugs, Dopaminergic; Dopamine Drugs; Drugs, Dopamine; Dopaminergic Agents; Agents, Dopaminergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150; D27.505.696.577.150;

Online Note: use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94

History Note: 95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS (NON MESH) was heading 1995

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs